A phase I/IIa clinical trial of CLAOP21 and CLAOP14 in patients with high grade non-Hodgkins lymphoma.

scientific article published in September 2007

A phase I/IIa clinical trial of CLAOP21 and CLAOP14 in patients with high grade non-Hodgkins lymphoma. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1080/10428190701534432
P698PubMed publication ID17786711

P50authorGero HütterQ111708
Eckhard ThielQ87582542
Ulrich KeilholzQ107526958
P2093author name stringAlexander Schmittel
Antonia Busse
Jan Michael Siehl
P2860cites workCHOP-rituximab with pegylated liposomal doxorubicin for the treatment of elderly patients with diffuse large B-cell lymphomaQ28270920
Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphomaQ28297805
Survival in patients with intermediate or high grade non-Hodgkin's lymphoma: meta-analysis of randomized studies comparing third generation regimens with CHOPQ28346778
Pegylated liposomal doxorubicin in combination chemotherapy in the treatment of previously untreated aggressive diffuse large-B-cell lymphomaQ33342531
Congestive heart failure in patients treated with doxorubicin: a retrospective analysis of three trialsQ34199968
Pegylated liposomal doxorubicin (doxil): reduced clinical cardiotoxicity in patients reaching or exceeding cumulative doses of 500 mg/m2.Q34511480
Pegfilgrastim: using pegylation technology to improve neutropenia support in cancer patientsQ35101292
Pharmacokinetics of pegylated liposomal Doxorubicin: review of animal and human studiesQ35124674
Cardiac safety of liposomal anthracyclinesQ35297464
Liposome-encapsulated doxorubicin compared with conventional doxorubicin in a randomized multicenter trial as first-line therapy of metastatic breast carcinomaQ43869754
Treatment results of aggressive B non-Hodgkin's lymphoma in advanced age considering comorbidityQ44220317
Early cardiotoxicity of the CHOP regimen in aggressive non-Hodgkin's lymphomaQ44299826
Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of elderly patients with aggressive lymphomas: results of the NHL-B2 trial of the DSHNHL.Q44796944
Dose-related vincristine-induced peripheral neuropathy with unexpected off-therapy worseningQ46395878
A Phase II trial of pegylated liposomal doxorubicin, vincristine, and reduced-dose dexamethasone combination therapy in newly diagnosed multiple myeloma patients.Q53951659
P433issue9
P921main subjectphase I clinical trialQ5452194
P304page(s)1755-1763
P577publication date2007-09-01
P1433published inLeukemia & LymphomaQ6534493
P1476titleA phase I/IIa clinical trial of CLAOP21 and CLAOP14 in patients with high grade non-Hodgkins lymphoma.
P478volume48

Search more.